Page last updated: 2024-11-05

trimethoprim and Abnormalities, Congenital

trimethoprim has been researched along with Abnormalities, Congenital in 2 studies

Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jaffe, P1
Liberman, MM1
McFadyen, I1
Valman, HB1
Nguyen, BT1
Stadtsbaeder, S1

Other Studies

2 other studies available for trimethoprim and Abnormalities, Congenital

ArticleYear
Letter: Incidence of congenital limb-reduction deformities.
    Lancet (London, England), 1975, Mar-01, Volume: 1, Issue:7905

    Topics: Abnormalities, Drug-Induced; Arm; Benzyl Compounds; Birth Weight; Congenital Abnormalities; England;

1975
Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole) and spiramycin in pregnant mice infected with Toxoplasma gondii (Beverley strain).
    British journal of pharmacology, 1985, Volume: 85, Issue:3

    Topics: Animals; Antibodies; Birth Weight; Congenital Abnormalities; Delivery, Obstetric; Drug Combinations;

1985